Pourrat O, Robert R, Neau J P, Deleplanque P, Alcalay D
Service de Clinique Médicale B, Hôpital Jean-Bernard, Cité Hospitalière de la Milètrie, Poitiers.
Ann Med Interne (Paris). 1988;139 Suppl 1:51-2.
A patient with myasthenia receiving treatment with anticholinesterase agents and plasma exchanges for an acute episode, developed three successive periods of neurological deterioration during which plasma cholinesterase levels were determined. The risk of onset of a cholinergic crisis under these circumstances has been reported in the literature but not documented. The accidents in the present case were related to cumulative overdose effects of anticholinesterase agents and depletion of cholinesterase, suggesting caution in the use of anticholinesterase agents when frequent plasma exchanges are being carried out in a patient with myasthenia.
一名重症肌无力患者在接受抗胆碱酯酶药物治疗并进行血浆置换以应对急性发作期间,出现了连续三个神经功能恶化阶段,在此期间测定了血浆胆碱酯酶水平。文献中曾报道过在这种情况下发生胆碱能危象的风险,但尚无记录。本病例中的意外情况与抗胆碱酯酶药物的累积过量效应及胆碱酯酶耗竭有关,提示在对重症肌无力患者频繁进行血浆置换时,使用抗胆碱酯酶药物需谨慎。